NO20064185L - Pyrazolin derivater nyttige for bahandling av kreft - Google Patents

Pyrazolin derivater nyttige for bahandling av kreft

Info

Publication number
NO20064185L
NO20064185L NO20064185A NO20064185A NO20064185L NO 20064185 L NO20064185 L NO 20064185L NO 20064185 A NO20064185 A NO 20064185A NO 20064185 A NO20064185 A NO 20064185A NO 20064185 L NO20064185 L NO 20064185L
Authority
NO
Norway
Prior art keywords
cancer
treatment
compounds
derivatives useful
pyrazoline derivatives
Prior art date
Application number
NO20064185A
Other languages
English (en)
Inventor
Jordi Frigola Constansa
Rosa Cuberes Altisen
Ramon Mangues Bafalluy
Isolda Casanova Rigal
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES200400362A external-priority patent/ES2238923B1/es
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of NO20064185L publication Critical patent/NO20064185L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Foreliggende oppfinnels angår nye substituerte prazolinforbindelser, farmasøytiske sammensetninger inneholdende slike forbindelser og anvendelsen av disse forbindelsene for behandling av cancer, spesielt for behandlingen av hjernecancer, bencancer, leppecancer, munncancer, øsofagal cancer, magecancer, levercancer, blærecancer, pancreascancer, ovariecancer, cervical cancer, lungecancer, brystcancer, hudcancer, spesielt for behandlingen av coloncancer og/eller tarmcancer og/eller prostatacancer.
NO20064185A 2004-02-16 2006-09-15 Pyrazolin derivater nyttige for bahandling av kreft NO20064185L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200400362A ES2238923B1 (es) 2004-02-16 2004-02-16 Nuevos derivados pirazolinicos sustituidos.
US10/804,695 US20050182119A1 (en) 2004-02-16 2004-03-19 Substituted pyrazoline derivatives
PCT/EP2005/001656 WO2005077910A1 (en) 2004-02-16 2005-02-16 Pyrazoline derivatives useful for the treatment of cancer

Publications (1)

Publication Number Publication Date
NO20064185L true NO20064185L (no) 2006-11-13

Family

ID=34863166

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064185A NO20064185L (no) 2004-02-16 2006-09-15 Pyrazolin derivater nyttige for bahandling av kreft

Country Status (9)

Country Link
EP (1) EP1718618A1 (no)
JP (1) JP2007522180A (no)
KR (1) KR20070044799A (no)
AU (1) AU2005212833A1 (no)
BR (1) BRPI0507718A (no)
CA (1) CA2556478A1 (no)
NO (1) NO20064185L (no)
RU (1) RU2006133150A (no)
WO (1) WO2005077910A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008308473A (ja) * 2007-06-18 2008-12-25 Japan Health Science Foundation 癌治療剤
CN101735150B (zh) * 2009-12-16 2011-12-28 南京大学 一类含有吡唑环的硫脲类衍生物及其制法和用途
CN101759695B (zh) * 2009-12-30 2011-09-14 南京大学 一类含有吡唑环的噻唑类衍生物及其制法和用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE361748T1 (de) * 1999-06-16 2007-06-15 Univ Temple 1-(4-sulfamylphenyl)-3-trifluormethyl-5-aryl-2- pyrazoline als cyclooxygenase-2 inhibitoren
ES2174757B1 (es) * 2001-04-06 2003-11-01 Esteve Labor Dr Empleo de derivados de firazolinas en la elaboracion de un medicamentopara la prevencion y/o el tratamiento de enfermedades proliferativas celulares.

Also Published As

Publication number Publication date
KR20070044799A (ko) 2007-04-30
CA2556478A1 (en) 2005-08-25
BRPI0507718A (pt) 2007-07-03
AU2005212833A1 (en) 2005-08-25
JP2007522180A (ja) 2007-08-09
EP1718618A1 (en) 2006-11-08
RU2006133150A (ru) 2008-04-10
WO2005077910A1 (en) 2005-08-25

Similar Documents

Publication Publication Date Title
IL260127B (en) mek inhibitors and methods of using them
UA99731C2 (ru) Кристаллические полиморфные формы n-(ариламино)сульфонамидов как ингибиторы мэк, композиция (варианты) и применение
WO2008008430A3 (en) Micro-rna-based methods and compositions for the diagnosis and treatment of colon cancer-related diseases
NO20071794L (no) Disubstituerte pyrazolobenzodiazepiner nyttige som inhibitorer for CDK2 og angiogenese, og for behandling av bryst, tarm, lunge og prostata cancer
EA200802050A1 (ru) Новые гетероарилзамещенные ариламинопиридиновые производные в качестве мек ингибиторов
EA201690265A2 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
MXPA05012061A (es) Preparacion y uso de derivados alquilarilo para el tratamiento de la obesidad.
TN2010000049A1 (en) Derivatives of n-(arylamino) sulfonamides includig polymorphs as inhibitors of mek as well as compositions, methods of use and methods for preparing the same
EA200700321A1 (ru) Пиразолзамещённые аминогетероарильные соединения в качестве ингибиторов протеинкиназы
NO20054361D0 (no) Benzensylfonamidderivater, fremgangsmate for fremstilling og anvendelse derav for behandlig av smerte
TW200724537A (en) Pyrimidine derivatives for treatment of hyperproliferative disorders
EA201070713A1 (ru) Твердые лекарственные формы
EP1817312A4 (en) MACROCYCLIC AMINIOPYRIDYL BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF MORBUS ALZHEIMER
EA200702037A1 (ru) Пищевая композиция для связывания ацетальдегида во рту и пищевом тракте и способ её приготовления
MY150098A (en) Benzylpiperazine derivates and their medical use
DK1727817T3 (da) Azabicyclooctan-3-onderivativer og anvendelse heraf
NO20073725L (no) CCI-779-polymorf og dens anvendelse
EP1812007A4 (en) PYRIDAZINE COMPOUNDS AND METHODS
NO20064185L (no) Pyrazolin derivater nyttige for bahandling av kreft
ATE435224T1 (de) Neue piperidinsubstituierte diaminothiazole
EA201500218A1 (ru) Антрахинондиоксимы и их применение
BRPI0415355A (pt) triarilimidazóis
NO20090539L (no) Azaindolderivater med en kombinasjon av partiell nikotinacetylcholinreseptoragonisme og dopamin gjenopptakelsesinhibisjon
BRPI0511826A (pt) derivados de 2,4-diaminotiazol-5-ona
ATE432933T1 (de) Flavopereirinderivate zur krebstherapie

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application